Date |
Time |
Hall |
Session |
Role |
Title |
Name |
2018-10-19 |
13:30-13:40 |
Conference Hall No.5-D(1F) |
VTE |
Symposium |
United states pharmacopoeia potency adjusted bovine mucosal heparins are comparable to porcine mucosal heparin at equivalent levels |
Evi Kalodiki |
2018-10-19 |
13:30-14:20 |
Conference Hall No.5-D(1F) |
VTE |
Moderator |
|
Evi Kalodiki |
2018-10-19 |
14:40-16:00 |
Conference Hall No.5-C(1F) |
Chronic Venous Disease---Satellite Meeting for Medi GmbH & Co. KG |
Moderator |
|
Evi Kalodiki |
2018-10-19 |
15:20-15:30 |
Conference Hall No.5-C(1F) |
Chronic Venous Disease---Satellite Meeting for Medi GmbH & Co. KG |
Symposium |
The venous drainage index quantifies venous obstrauction |
Evi Kalodiki |
2018-10-19 |
17:20-17:30 |
Conference Hall No.5-C(1F) |
Varicose veins |
Symposium |
Water compresses superficial veins, stockings do not |
Evi Kalodiki |
2018-10-20 |
10:50-11:05 |
Conference Hall No.5-A(1F) |
An update on the management of DVT (Sponsored by Alfa sigma) |
Symposium |
Criterion to Determine Optimal Duration of Anticoagulation |
Evi Kalodiki |
2018-10-20 |
12:30-13:30 |
Electronic Poster Machine:Conference Hall No.4(1F) |
Poster session-Part 3 (each poster has 5 minutes’presentation and 1 minutes’question and answer) |
Moderator |
|
Evi Kalodiki |
2018-10-20 |
17:45-17:55 |
Conference Hall No.2-B(2F) |
ESVM-IUA: Unresolved issues in VTED management (Simultaneous Interpretation ) |
Symposium |
Unresolved issues in superficial venous thrombosis |
Evi Kalodiki |